Sale
SARS-COV-2 Spike S1 (N501Y) Protein (COV-VM1SY)
$270.00 – $900.00
KACTUS Biosystems SARS-COV-2 Spike S1 (N501Y) Protein (COV-VM1SY) (catalog No. COV-VM1SY) is expressed from HEK293 with His tag at the C-Terminus.It contains Val16-Arg685.
- Details & Specifications
- References
- More Offers
Catalog No. | COV-VM1SY |
---|---|
Product Name | SARS-COV-2 Spike S1 (N501Y) Protein (COV-VM1SY) |
Supplier Name | KACTUS Biosystems |
Brand Name | KACTUS Biosystems |
Synonyms | S1 protein; Spike protein S1; Spike,S1 protein; S glycoprotein Subunit1 |
Species | SARS-COV-2 |
Source | HEK293 |
Accession | YP_009724390.1 |
Product Tag | C-His |
Biotinylated | no |
Exact Sequence | Val16-Arg685 |
Molecular Weight | The protein has a predicted MW of 76 kDa. Due to glycosylation, the protein migrates to 115-140 kDa based on Tris-Bis PAGE result. |
Form | Lyophilized |
Formulation | Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. |
Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
Endotoxin | Less than 1EU per μg by the LAL method. |
Shipping | Shipped at ambient temperature. |
Stability & Storage | '-20 to -80°C for 12 months as supplied from date of receipt.; -20 to -80°C for 3-6 months in unopened state after reconstitution.; 2-8°C for 2-7 days after reconstitution.; Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles. |
Note | Products will be shipped from the warehouse in Massachusetts. Promotion is running from time to time. Welcome to send a request for quote to message@sydlabs.com. |
Order Offline | Syd Labs, Inc. 4 Avenue E, Hopkinton, MA 01748 USA. Phone: 1-617-401-8149 Fax: 1-617-606-5019 Email: message@sydlabs.com |
Description
COV-VM1SY: SARS-COV-2 Spike S1 (N501Y) Protein (COV-VM1SY)
A new variant of SARS-CoV-2 is spreading in the UK and is rapidly becoming a global threat.It is characterised by multiple mutations in the spike protein. Among them, N501Y is of major concern because it involves one of the six key amino acid residues determining a tight interaction of the SARS-CoV-2 receptor-binding domain (RBD) with its cellular receptor angiotensin-converting enzyme 2 (ACE2).
Please remember our product information: SARS-COV-2 Spike S1 (N501Y) Protein (COV-VM1SY) catalog number: COV-VM1SY KACTUS Biosystems
No more offers for this product!